These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 30589580

  • 1. Metacognitive therapy for obsessive-compulsive disorder: A case report.
    Melchior K, Franken IHA, van der Heiden C.
    Bull Menninger Clin; 2018; 82(4):375-389. PubMed ID: 30589580
    [Abstract] [Full Text] [Related]

  • 2. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
    Melchior K, Franken I, Deen M, van der Heiden C.
    Trials; 2019 May 20; 20(1):277. PubMed ID: 31109349
    [Abstract] [Full Text] [Related]

  • 3. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder - A non-inferiority randomized controlled trial.
    Exner C, Kleiman A, Haberkamp A, Hansmeier J, Milde C, Glombiewski JA.
    J Anxiety Disord; 2024 Jun 20; 104():102873. PubMed ID: 38729024
    [Abstract] [Full Text] [Related]

  • 4. Using Family-Based Exposure With Response Prevention to Treat Obsessive-Compulsive Disorder in Young Children: A Case Study.
    Herren J, Freeman J, Garcia A.
    J Clin Psychol; 2016 Nov 20; 72(11):1152-1161. PubMed ID: 27684498
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
    Rector NA, Richter MA, Katz D, Leybman M.
    Br J Clin Psychol; 2019 Mar 20; 58(1):1-18. PubMed ID: 29984550
    [Abstract] [Full Text] [Related]

  • 8. Does Exposure and Response Prevention Behaviorally Activate Patients With Obsessive-Compulsive Disorder? A Preliminary Test.
    Blakey SM, Abramowitz JS, Leonard RC, Riemann BC.
    Behav Ther; 2019 Jan 20; 50(1):214-224. PubMed ID: 30661561
    [Abstract] [Full Text] [Related]

  • 9. Enhancing exposure and response prevention for OCD: a couple-based approach.
    Abramowitz JS, Baucom DH, Wheaton MG, Boeding S, Fabricant LE, Paprocki C, Fischer MS.
    Behav Modif; 2013 Mar 20; 37(2):189-210. PubMed ID: 22619395
    [Abstract] [Full Text] [Related]

  • 10. Experimental modification of beliefs in obsessive-compulsive disorder: a test of the metacognitive model.
    Fisher PL, Wells A.
    Behav Res Ther; 2005 Jun 20; 43(6):821-9. PubMed ID: 15890171
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metacognitive Training for Obsessive-Compulsive Disorder: a study protocol for a randomized controlled trial.
    Miegel F, Demiralay C, Moritz S, Wirtz J, Hottenrott B, Jelinek L.
    BMC Psychiatry; 2020 Jul 06; 20(1):350. PubMed ID: 32631261
    [Abstract] [Full Text] [Related]

  • 13. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences.
    Schneider SC, Knott L, Cepeda SL, Hana LM, McIngvale E, Goodman WK, Storch EA.
    Depress Anxiety; 2020 May 06; 37(5):418-428. PubMed ID: 32048376
    [Abstract] [Full Text] [Related]

  • 14. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ, Waters AM, Boschen MJ, Hattingh L, McConnell H, Milliner EL, Collings N, Zimmer-Gembeck M, Shelton D, Ollendick TH, Testa C, Storch EA.
    Depress Anxiety; 2013 Aug 06; 30(8):723-31. PubMed ID: 23722990
    [Abstract] [Full Text] [Related]

  • 15. A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder.
    Johnco C, McGuire JF, Roper T, Storch EA.
    Depress Anxiety; 2020 May 06; 37(5):407-417. PubMed ID: 31778595
    [Abstract] [Full Text] [Related]

  • 16. Session-specific effects of the Metacognitive Group Training for Obsessive-Compulsive Disorder: significant results for thought control.
    Miegel F, Cludius B, Hottenrott B, Demiralay C, Jelinek L.
    Sci Rep; 2020 Oct 20; 10(1):17816. PubMed ID: 33082393
    [Abstract] [Full Text] [Related]

  • 17. An Avoidance-Based Rodent Model of Exposure With Response Prevention Therapy for Obsessive-Compulsive Disorder.
    Rodriguez-Romaguera J, Greenberg BD, Rasmussen SA, Quirk GJ.
    Biol Psychiatry; 2016 Oct 01; 80(7):534-40. PubMed ID: 27086546
    [Abstract] [Full Text] [Related]

  • 18. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
    van Oppen P, van Balkom AJ, Smit JH, Schuurmans J, van Dyck R, Emmelkamp PM.
    J Clin Psychiatry; 2010 Sep 01; 71(9):1158-67. PubMed ID: 20361906
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of Self-Conducted Exposure for OCD Using Cognitive Bias Modification: A Case Study.
    Najmi S, Amir N.
    J Clin Psychol; 2017 May 01; 73(5):536-546. PubMed ID: 28170102
    [Abstract] [Full Text] [Related]

  • 20. Association of metacognitive beliefs, obsessive beliefs and symptom severity with quality of life in obsessive-compulsive patients.
    Barahmand U, Tavakolian E, Alaei S.
    Arch Psychiatr Nurs; 2014 Oct 01; 28(5):345-51. PubMed ID: 25439977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.